Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
San Jose State University Research Foundation has 4 pending office actions in the Biotechnology & Pharmaceuticals sector. These actions are distributed among 4 distinct examiners across 3 distinct art units. WHITE, KIA XIONG is the busiest examiner, currently managing 1 busiest examiner pending action. The distribution of 4 pending office actions across 4 distinct examiners indicates that no single examiner has a majority share of the workload.
With 4 distinct examiners and 3 distinct art units, the portfolio is spread out for its size. WHITE, KIA XIONG is the busiest examiner with 1 pending action, which is the same amount as the other examiners. This lack of concentration means that prosecution success depends on the individual decisions of 4 different people. The 3 distinct art units involved suggest that the 4 pending office actions cover several different sub-specialties within the biotechnology field. Practitioners must manage 4 separate examiner relationships across 3 different organizational groups at the office.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| Multi-statute (no §101) | 3 (75%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WHITE, KIA XIONG | 1 | 66.0% | +44.1% |
| ROZOF, TIMOTHY R | 1 | 72.7% | +23.6% |
| CHU, YONG LIANG | 1 | 74.9% | +3.1% |
| ANGELES, JOSE | 1 | 36.8% | +50.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17929156 | MEDICAL PREMATURE INFANT MANNEQUIN | ANGELES, JOSE | 54d |
| 18759802 | LIGHTWEIGHT HIGH TORQUE EXOSKELETON | WHITE, KIA XIONG | — |
| 18021284 | ANTIBACTERIAL ADJUVANTS AND APPLICATIONS THEREOF | ROZOF, TIMOTHY R | — |
| 18056563 | FUNCTIONALIZED NANOSCALE DIAMONDS AND USES THEREOF | CHU, YONG LIANG | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17929156 | MEDICAL PREMATURE INFANT MANNEQUIN | ANGELES, JOSE | 54d |
| 18759802 | LIGHTWEIGHT HIGH TORQUE EXOSKELETON | WHITE, KIA XIONG | — |
| 18021284 | ANTIBACTERIAL ADJUVANTS AND APPLICATIONS THEREOF | ROZOF, TIMOTHY R | — |
| Art Unit | Apps |
|---|---|
| 1625 | 1 |
| 1731 | 1 |
| 3715 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18759802 | LIGHTWEIGHT HIGH TORQUE EXOSKELETON | WHITE, KIA XIONG | — | §102§112 | Non-Final OA | — | Pending | Jun 28, 2024 |
| 18021284 | ANTIBACTERIAL ADJUVANTS AND APPLICATIONS THEREOF | ROZOF, TIMOTHY R | 1625 | §101§102 | Non-Final OA | — | Pending | Feb 14, 2023 |
| 18056563 | FUNCTIONALIZED NANOSCALE DIAMONDS AND USES THEREOF | CHU, YONG LIANG | 1731 | §102§103§112 | Final Rejection | — | Pending | Nov 17, 2022 |
| 17929156 | MEDICAL PREMATURE INFANT MANNEQUIN | ANGELES, JOSE | 3715 | §103§112 | Final Rejection | 54d | Pending | Sep 01, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial